We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04119024
Brief Title: Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma

First Submitted : September 25, 2019
First Submitted that Met QC Criteria : October 4, 2019
First Posted : October 8, 2019

Last Update Submitted that Met QC Criteria : January 5, 2023
Last Update Posted : January 6, 2023